Skip to content
PeptideAgent

Compounding pharmacies in Maryland

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Maryland Board of Pharmacy (Maryland Department of Health) regulates compounding pharmacies in Maryland. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Maryland at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Maryland

No verified compounding pharmacies serving Maryland are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Maryland

The Maryland Board of Pharmacy regulates pharmacists and pharmacies under Health Occupations Article, Title 12, and COMAR Title 10, Subtitle 34, including COMAR 10.34.19 on sterile pharmaceutical compounding. Maryland has no state bulks list; eligibility of a peptide for compounding follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Under Health Occupations section 12-403, a nonresident pharmacy that dispenses to Maryland patients must hold a Maryland pharmacy permit, submit the most recent inspection report from its home-state regulator, and designate a Maryland agent for service of process. Maryland no longer issues a separate sterile compounding permit: Chapter 5 of the Acts of 2015 (Senate Bill 69) repealed the sterile compounding permit requirement. Instead, section 12-403 requires a nonresident pharmacy that will dispense compounded sterile preparations to Maryland patients to submit a report of an inspection, conducted within 90 days before its application by a Board designee or another Board-approved entity, that shows compliance with USP chapter 797, and to keep complying with USP chapter 797 and the Board's sterile compounding regulations. COMAR 10.34.37.04 likewise requires a nonresident pharmacy that compounds sterile preparations to follow USP standards and COMAR 10.34.19. [1] [3] [4] [5] [6] [8]

Compounded GLP-1 access in Maryland

Maryland's asynchronous telehealth rule makes app-based GLP-1 programs lawful on the prescribing side, but the dispensing pharmacy must still hold a Maryland pharmacy or nonresident pharmacy permit. [2] [3] [11]

Research use only sellers in Maryland

Maryland's Food, Drug, and Cosmetic Act (Health-General Article, Title 21) prohibits selling adulterated or misbranded drugs, and Health Occupations Title 12 limits dispensing of prescription drugs to permitted pharmacies and authorized practitioners. [1] [7] [12]

How to check a compounding pharmacy in Maryland

  1. Search the Maryland Board of Pharmacy (Maryland Department of Health) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Maryland requires before it ships to you. [1] [3] [4] [5] [6] [8]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Maryland. [1] [7] [12]

Common questions in Maryland

Can an out-of-state pharmacy ship compounded peptides to me in Maryland?

Only if it holds a Maryland nonresident pharmacy permit. Under Health Occupations section 12-403, the pharmacy must submit its latest home-state inspection report and name a Maryland agent for service of process, and a pharmacy that ships compounded sterile preparations such as injectable peptides must also file a USP chapter 797 inspection report from an inspection done within 90 days before its application. Search the Board of Pharmacy license verification before ordering. [1] [3]

Can a Maryland pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [8] [9] [10]

All peptide legal questions for Maryland

Sources

  1. [1]Maryland Board of Pharmacy
  2. [2]Maryland Code, Health Occupations section 1-1003, Telehealth clinical evaluation and prescribing
  3. [3]Maryland Code, Health Occupations section 12-403, Required standards (including nonresident pharmacies)
  4. [4]COMAR Title 10, Subtitle 34, Board of Pharmacy regulations
  5. [5]COMAR 10.34.37.04, Requirements for nonresident pharmacy operations
  6. [6]Maryland Senate Bill 69 (2015), Chapter 5: repeal of the sterile compounding permit requirement
  7. [7]Maryland Code, Health-General Title 21, Food, Drugs, and Cosmetics
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  10. [10]FDA: Pharmacy Compounding Advisory CommitteeFDA
  11. [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  12. [12]21 U.S.C. 331, Prohibited acts